Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Expanding the Value Metrics in Fixed-Budget Hea...
By
HEOR Staff Writer
August 20, 2024
Introduction Traditional cost-effectiveness analysis (CEA) has long been a cornerstone in healthcare decision-making. However, its reliance on measures li...
Addressing the Challenges of Value Attribution in Combination Therapies
Extension of BowelScreen to Ages 50-54: A Cost-Effectiveness Analysis
New Anti-Obesity Medications Should Be Considered Preventive Health Care
The Use of Target Product Profiles in Health Technology Development
Enhancing COPD Management: Insights from Recent Meta-Analysis on Utility Values
Revealing the Hidden Impact: Family Spillover Effects
Transformation of Health Technology Assessment in Türkiye
The Role of Pull Incentives in Addressing Antimicrobial Resistance
The Shift to Value-Based Drug Pricing in the United States
Healthcare Decision-Making with MCDA Framework: The Saudi Arabian Perspective
Health Technology Assessment in South Africa: Towards NHI
Quality-Adjusted Life Year (QALY) in Modern Healthcare Decision-Making
« Previous
1
…
4
5
6
7
8
…
12
Next »